FSTRX
Price
$35.14
Change
+$0.12 (+0.34%)
Updated
Oct 3 closing price
Net Assets
1.98B
RMEBX
Price
$62.55
Change
+$0.10 (+0.16%)
Updated
Oct 6 closing price
Net Assets
112.47B
Interact to see
Advertisement

FSTRX vs RMEBX

Header iconFSTRX vs RMEBX Comparison
Open Charts FSTRX vs RMEBXBanner chart's image
Federated Hermes MDT Large Cap Value A
Price$35.14
Change+$0.12 (+0.34%)
VolumeN/A
Net Assets1.98B
American Funds American Mutual R2E
Price$62.55
Change+$0.10 (+0.16%)
VolumeN/A
Net Assets112.47B
FSTRX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
FSTRX vs. RMEBX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSTRX is a Hold and RMEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 112B vs. FSTRX (1.98B). RMEBX pays higher dividends than FSTRX: RMEBX (1.05) vs FSTRX (0.82). FSTRX was incepted earlier than RMEBX: FSTRX (11 years) vs RMEBX (11 years). FSTRX (1.16) is less costly to investors than RMEBX (1.07). FSTRX is a more actively managed with annual turnover of: 69.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than FSTRX: RMEBX (250) vs FSTRX (1500). RMEBX annual gain was more profitable for investors over the last year : 7.29 vs. FSTRX (1.09). RMEBX return over 5 years is better than : 59.63 vs. FSTRX (42.47).
FSTRXRMEBXFSTRX / RMEBX
Total Expense Ratio0.991.0793%
Annual Report Gross Expense Ratio1.161.07108%
Fund Existence11 years11 years-
Gain YTD14.82514.812100%
Front Load6%N/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets1.98B112B2%
Annual Yield % from dividends0.821.0578%
Returns for 1 year1.097.2915%
Returns for 3 years35.9043.2483%
Returns for 5 years42.4759.6371%
Returns for 10 years43.3892.3747%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AARD17.050.97
+6.03%
Aardvark Therapeutics Inc
SAIA309.2811.86
+3.99%
Saia
ARCB73.501.52
+2.11%
ArcBest Corp
TVACU11.450.16
+1.42%
Texas Ventures Acquisition III Corp
PED0.57N/A
-0.64%
PEDEVCO Corp